4//SEC Filing
Grayson Paul A. 4
Accession 0001516551-23-000066
CIK 0001516551other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 7:25 PM ET
Size
5.6 KB
Accession
0001516551-23-000066
Insider Transaction Report
Form 4
Grayson Paul A.
Director
Transactions
- Award
Common Stock
2023-08-25+18,132,596→ 18,132,596 total
Footnotes (2)
- [F1]Represents a restricted stock unit ("RSU") award that vests on the following performance milestones : 25% vests upon achieving a market cap of $125M, an additional 25% vests upon achieving a market cap of $250M, an additional 25% vests upon achieving a market cap of $400M, an additional 25% vest at an exit of $500M or greater; provided, however, that no RSUs shall vest until the compensation committee of the Issuer determines that shares can be sold into the market to cover withholding tax obligations associated with the vesting of the RSUs . Notwithstanding anything to the foregoing, all of the RSUS shall vest if an exit greater than $500M is achieved at an earlier date.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Documents
Issuer
Skye Bioscience, Inc.
CIK 0001516551
Entity typeother
Related Parties
1- filerCIK 0001861554
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 7:25 PM ET
- Size
- 5.6 KB